Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall
- PMID: 2359181
- DOI: 10.1016/s0022-5347(17)39365-5
Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall
Abstract
The antitumoral effects of intravesical bacillus Calmette-Guerin against recurrent superficial urothelial bladder cancer seem to be linked to immunological effector mechanisms. To characterize further the local cellular response in the bladder wall of patients receiving intravesical bacillus Calmette-Guerin bladder biopsies were examined before and immediately after a 6-week course of bacillus Calmette-Guerin and for up to 1 year at 3-month intervals thereafter. The results showed a marked infiltration after bacillus Calmette-Guerin therapy predominantly of the suburothelial tissue with mononuclear cells, which expressed activation markers and accumulated to follicle-like granulomatous structures. With regard to T lymphocyte subsets the ratio of T helper-to-T suppressor cells in the bladder wall increased from 0.5 to nearly 2. This phenomenon persisted even in biopsies 1 year after initial treatment. In some probes activated mononuclear cells invaded the urothelium, emanating from suburothelial granulomas. It is tempting to assume that these changes within the local immunocompetent cells are related to the therapeutic effect of bacillus Calmette-Guerin against bladder cancer.
Similar articles
-
Long-term immunobiological effects of intravesical bacillus Calmette-Guérin against bladder carcinoma recurrences.Dev Biol Stand. 1992;77:199-209. Dev Biol Stand. 1992. PMID: 1426663
-
The response of patients with superficial bladder cancer to a second course of intravesical bacillus Calmette-Guerin.J Urol. 1990 Apr;143(4):710-2; discussion 712-3. doi: 10.1016/s0022-5347(17)40067-x. J Urol. 1990. PMID: 2313796
-
Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors.J Urol. 1990 Dec;144(6):1362-4. doi: 10.1016/s0022-5347(17)39741-0. J Urol. 1990. PMID: 2231927
-
Use of intravesical bacillus Calmette-Guérin in the treatment of superficial transitional cell carcinoma of the bladder: an overview.Urol Int. 1990;45(3):129-36. doi: 10.1159/000281694. Urol Int. 1990. PMID: 2190404 Review.
-
Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.J Urol. 2017 May;197(5):1189-1199. doi: 10.1016/j.juro.2016.12.090. Epub 2016 Dec 24. J Urol. 2017. PMID: 28027868
Cited by
-
Recombinant bacille Calmette-Guérin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicity.Clin Exp Immunol. 2001 Feb;123(2):264-70. doi: 10.1046/j.1365-2249.2001.01428.x. Clin Exp Immunol. 2001. PMID: 11207657 Free PMC article.
-
The mechanism of action of BCG therapy for bladder cancer--a current perspective.Nat Rev Urol. 2014 Mar;11(3):153-62. doi: 10.1038/nrurol.2014.15. Epub 2014 Feb 4. Nat Rev Urol. 2014. PMID: 24492433 Review.
-
Intravesical Bacillus Calmette-Guerin and its complications: 12 years of learning experience in a single local institution.Singapore Med J. 2022 Jun;63(6):325-329. doi: 10.11622/smedj.2020168. Epub 2020 Dec 2. Singapore Med J. 2022. PMID: 36043299 Free PMC article.
-
Morphological aspects of the interaction of Bacillus Calmette-Guérin with urothelial bladder cells in vivo and in vitro: relevance for antitumor activity?Urol Res. 1992;20(3):219-28. doi: 10.1007/BF00299721. Urol Res. 1992. PMID: 1615584
-
Enhancing effect of an inhibitor of nitric oxide synthesis on bacillus Calmette-Guerin-induced macrophage cytotoxicity against murine bladder cancer cell line MBT-2 in vitro.Jpn J Cancer Res. 2000 May;91(5):534-42. doi: 10.1111/j.1349-7006.2000.tb00978.x. Jpn J Cancer Res. 2000. PMID: 10835499 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical